Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05003739
Other study ID # H-37
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 7, 2021
Est. completion date June 30, 2026

Study information

Verified date September 2023
Source Limacorporate S.p.a
Contact Federica Azzimonti
Phone +39 377 5450940
Email federica.azzimonti@limacorporate.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Logica Mirror femoral stem is a CE marked medical device, and within this clinical trial it is used according to its intended use. This is a Post Marketing Clinical Follow Up trial, with the main aim to collect additional evidences on the outcome data on this product, by analysing clinical scoring systems, radiographs and adverse event records within three years after the surgery, and thus to assess the short-term performance and safety of this implant.


Recruitment information / eligibility

Status Recruiting
Enrollment 62
Est. completion date June 30, 2026
Est. primary completion date June 30, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility All patients that underwent partial or total hip arthroplasty and implanted with LOGICA MIRROR femoral stem between Jan 2010 and Dec 2021 at Nemocnice Kyjov Hospital (CZ) in accordance with the indication for use of the product and site standard of practice. Additional Inclusion criteria: - Availability of patients' immediate post-operative radiograph (baseline) and of a number of follow-up x-rays that the Principal Investigator deems sufficient for an effective radiographic implant evaluation and stability assessment; - Patient is willing and able to complete additional follow-up evaluations if needed after signing ICF. Exclusion criteria - Age < 18 years; - Female patients who are pregnant, nursing, or planning a pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Hip arthroplasty with Logica Mirror femoral stem
Total or partial hip arthroplasty with implant of Logica Mirror femoral stem

Locations

Country Name City State
Czechia Nemocnice Kyjov Hospital Kyjov CZ Republic

Sponsors (1)

Lead Sponsor Collaborator
Limacorporate S.p.a

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Harris Hip Score - Functional change between preop and 3 years FU Functional change in Harris Hip Score (HHS) from preoperative (baseline) to 3 years after surgery.
The maximum score of HHS is 100 points. Pain domain contributes 44 points, function 47, ROM 5 and absence of deformity 4 points.
Results can be interpreted with the following: Less than 60= failed result; 60 to 69= poor result; 70 to 79= fair; 80 to 90= good; 90 to 100= excellent;
3 years
Secondary Harris Hip Score - Functional change between preop and 6 weeks FU, 3 months FU, 1 year FU Functional change in Harris Hip Score between preoperative (baseline) and 6 weeks FU, 3 months FU, 1 year FU; 6 weeks, 3 months, 1 year
Secondary Oxford Hip Score - Functional change between preop and 6 weeks FU, 3 months FU, 1 year FU, 3 years FU Functional change in Oxford Hip Score between preoperative (baseline) and 6 weeks FU, 3 months FU, 1 year FU, 3 years FU. The OHS is a short 12-item survey. It comprises two domains (pain and function), with six items or questions in each, using the following scoring: each question has been scored between 0 and 4, with 4 being the best outcome, producing overall scores running from 0 to 48, with 48 being the best outcome.
The calculation of the total score of OHS is based on this scoring system and the resulted score can be interpreted as follows: less than 27 points= poor; 27 to 33 points= fair; 34 to 41 points= good; 41 to 48 points= excellent
6 weeks, 3 months, 1 year, 3 years
Secondary VAS satisfaction Functional evaluation of VAS satisfaction at 6 weeks FU, 3 months FU, 1 year FU, 3 years FU;
Patient is asked to rate his satisfaction by making a vertical mark on the 100-mm line. The measurement in millimetres is eventually converted to the same number of points ranging from 0 to 100 points
6 weeks, 3 months, 1 year, 3 years
Secondary Radiographic implant evaluation and stability assessment of Logica Mirror stem Stability assessment of Logica Mirror stem (through radiographic implant evaluation) at the following timepoints: at discharge, 6 weeks, 3 months, 1 year, 3 years.
For assessing the stability of the femoral component in a cemented configuration, the presence of radiolucent lines should be recorded both at stem-cement interface and at cement-bone interface.
At each postoperative time-point the radiolucencies will be measured in every Gruen zone and graded in accordance to the following classification:
None: No evidence of radiolucency
mm: Presence of 1 mm-width radiolucent lines
mm: Presence of 2 mm-width radiolucent lines > 2 mm: Presence of radiolucent lines wider than 2 mm
At discharge, 6 weeks, 3 months, 1 year, 3 years
Secondary Survival rate of the implant at 3 years after surgery Survival rate of the implant (Kaplan-Meier) at 3 years after surgery 3 years
Secondary Safety profile of Logica Mirror by recording adverse events (AE), serious adverse events (SAE), device deficiency (DD), adverse device effect (ADE), serious adverse device effect (SADE) Incidence of device-related adverse events( AE), serious adverse events (SAE), device deficiency (DD), adverse device effect (ADE), serious adverse device effect (SADE) at every follow-up (intraoperative, immediate post-operative, 6 weeks, 3 months, 1 year, 3 years). up to 3 years
See also
  Status Clinical Trial Phase
Withdrawn NCT04989998 - Patient Outcomes Using HIP7 Software as Compared to Conventional THA N/A
Completed NCT02062437 - Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair N/A
Active, not recruiting NCT04322916 - Clinical Study With the RM Pressfit Vitamys Cup in Combination With a Mathys Stem
Recruiting NCT04199377 - Retrospective Evaluation of Clinical and Functional Results and Survivorship of Total Knee Replacement and Total Hip Replacement, Both Isolated or Combined. N/A
Active, not recruiting NCT00664508 - Mobility Assessment of Patients With Total Hip Arthroplasty N/A
Completed NCT05627544 - Blood Transfusion Applications in Hip Replacements
Enrolling by invitation NCT03610789 - A Multicenter, Post-Market Clinical Follow-up Study of Subjects With the REDAPTâ„¢ System Monolithic Sleeveless/Sleeved Stem and/or Fully Porous Acetabular Shell With XLPE Liner and/or Modular Shell Components Previously Implanted
Recruiting NCT02230826 - Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
Recruiting NCT02188199 - C3 Total Joint Patient Registry N/A
Completed NCT00398216 - A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery Phase 2
Completed NCT00328939 - ARIXTRA Local Study For Registration In China. Phase 3
Completed NCT02382835 - Metal-on-metal Hip Prostheses: Do They Have Systemic Effects? N/A
Completed NCT05343195 - Balance and Leg Function After Hip Replacement N/A
Completed NCT04979104 - Hip Arthroplasty With SL Cementless N/A
Recruiting NCT06178185 - A Novel Study Evaluating Patients Awaiting Total Hip Arthroplasty (PRIORITEES)
Not yet recruiting NCT04886570 - Clinical Follow-up of Hip Arthroplasty: A Cross-section and Longitudinal Study
Completed NCT02707302 - Surgical Adhesive Drapes for Prevention and Healing of Wound Infections After Total Hip Arthroplasty N/A
Recruiting NCT06161194 - Efficacy of Real-time Feedback Exercise Therapy in Patients Following Total Hip Arthroplasty N/A
Completed NCT05184725 - CARINAE for Stress Relief in Perioperative Care N/A
Completed NCT05710107 - QL vs PENG for Analgesia After Hip Arthroplasty N/A